Find AZD0780 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2455427-91-3, Azd-0780, 1-[6-[[(1s,3s)-3-[[5-(difluoromethoxy)pyrimidin-2-yl]amino]cyclopentyl]amino]pyridin-3-yl]pyridin-2-one, Schembl22241911, Gtpl13419, Azd0780
Molecular Formula
C20H20F2N6O2
Molecular Weight
414.4  g/mol
InChI Key
NCHUWRLOTSAFFN-KBPBESRZSA-N

AZD0780
1 2D Structure

AZD0780

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[6-[[(1S,3S)-3-[[5-(difluoromethoxy)pyrimidin-2-yl]amino]cyclopentyl]amino]pyridin-3-yl]pyridin-2-one
2.1.2 InChI
InChI=1S/C20H20F2N6O2/c21-19(22)30-16-11-24-20(25-12-16)27-14-5-4-13(9-14)26-17-7-6-15(10-23-17)28-8-2-1-3-18(28)29/h1-3,6-8,10-14,19H,4-5,9H2,(H,23,26)(H,24,25,27)/t13-,14-/m0/s1
2.1.3 InChI Key
NCHUWRLOTSAFFN-KBPBESRZSA-N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 2455427-91-3

2. Azd-0780

3. 1-[6-[[(1s,3s)-3-[[5-(difluoromethoxy)pyrimidin-2-yl]amino]cyclopentyl]amino]pyridin-3-yl]pyridin-2-one

4. Schembl22241911

5. Gtpl13419

6. Azd0780

7. Nchuwrlotsaffn-kbpbesrzsa-n

8. Bdbm537931

9. Ex-a6975

10. Us11248001, Example 458b

11. Example 458b [us11248001b2]

12. Da-76642

13. Ms-27171

14. Hy-148673

15. Cs-0636856

2.3 Create Date
2020-09-28
3 Chemical and Physical Properties
Molecular Weight 414.4 g/mol
Molecular Formula C20H20F2N6O2
XLogP33.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count7
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area92.3
Heavy Atom Count30
Formal Charge0
Complexity641
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Drugs in Development

read-more
read-more

Details:

AstraZeneca will receive access to CSPC’s pre-clinical candidate small molecule, YS2302018, an oral Lp(a) disruptor, with the aim of developing in a range of cardiovascular disease.


Lead Product(s): YS2302018,AZD0780

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: YS2302018

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: AstraZeneca

Deal Size: $2,020.0 million Upfront Cash: $100.0 million

Deal Type: Licensing Agreement October 07, 2024

blank

01

CPHI Middle east
Not Confirmed
CPHI Middle east
Not Confirmed

Details : AstraZeneca will receive access to CSPC’s pre-clinical candidate small molecule, YS2302018, an oral Lp(a) disruptor, with the aim of developing in a range of cardiovascular disease.

Brand Name : YS2302018

Molecule Type : Small molecule

Upfront Cash : $100.0 million

October 07, 2024

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty